Citation Impact
Citing Papers
Dominant-Negative Histone H3 Lysine 27 Mutant Derepresses Silenced Tumor Suppressor Genes and Reverses the Drug-Resistant Phenotype in Cancer Cells
2006
Epigenetic Resensitization to Platinum in Ovarian Cancer
2012
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Circulating Tumor-Specific DNA: A Marker for Monitoring Efficacy of Adjuvant Therapy in Cancer Patients
2005
The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
2008 Standout
Expression and Functions of Transmembrane Mucin MUC13 in Ovarian Cancer
2009
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Quercetin: a natural compound for ovarian cancer treatment
2019
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
The tor pathway: a target for cancer therapy
2004 Standout
Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1
2010 Standout
The dominance of the microenvironment in breast and ovarian cancer
2002
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Characterization of the Human TESTIN Gene Localized in the FRA7G Region at 7q31.2
2000
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
2005 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
A matter of life and death
2002 Standout
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Differential Methylation Profile of Ovarian Cancer in Tissues and Plasma
2008
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
2009
Hyaluronidase reduces human breast cancer xenografts in SCID mice
2002
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
2016 Standout
Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?
2001
The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein
2001
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
2004 Standout
Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients
2013
Social Relationships and Mortality Risk: A Meta-analytic Review
2010 Standout
The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications—a review
2013
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Mucins in ovarian cancer diagnosis and therapy
2009
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Defective Cytochrome c-dependent Caspase Activation in Ovarian Cancer Cell Lines due to Diminished or Absent Apoptotic Protease Activating Factor-1 Activity
2001
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Origins and molecular pathology of ovarian cancer
2005
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
2005
Contemporary Beliefs About Mental Illness Among Medical Students: Implications for Education and Practice
1990
Apoptosis
2002 Standout
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
2013 Standout
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Clinical risk factors for placenta previa–placenta accreta
1997 Standout
Gender, age and surgery as a treatment modality leads to higher distress in patients with cancer
2010
Impact of Adjuvant Radiation on Survival: A Note of Caution When Using Cancer Registry Data to Evaluate Adjuvant Treatments
2007
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
How stigma interferes with mental health care.
2004 Standout
The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13
2013
Cisplatin: The first metal based anticancer drug
2019 Standout
Placenta Accreta, Increta, and Percreta
2013
Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium
2006
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Social Support and Health: A Review of Physiological Processes Potentially Underlying Links to Disease Outcomes
2006 Standout
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer
1999
Endometriosis: pathogenesis and treatment
2013 Standout
Circulating nucleic acids (CNAs) and cancer—A survey
2006
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
2003
The 'incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention
2011
Long-term quality of life in Australian women previously diagnosed with gynaecologic cancer
2010
Ovarian Cancer Development and Metastasis
2010
Plasma cell‐free DNA in ovarian cancer
2010
Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age
2012 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study
2018
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Matrix Metalloproteinase 9 Is a Mediator of Epidermal Growth Factor–Dependent E-Cadherin Loss in Ovarian Carcinoma Cells
2008
Cancer statistics for African American/Black People 2022
2022
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Social Support, Psychological Distress, and Natural Killer Cell Activity in Ovarian Cancer
2005
Breast Cancer Statistics, 2022
2022 Standout
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
2003 Standout
Association of Circulating Tumor Cells with Serum Tumor-Related Methylated DNA in Peripheral Blood of Melanoma Patients
2006
Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.
2003
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Photoacoustic Tomography: In Vivo Imaging from Organelles to Organs
2012 StandoutScience
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Interleukin-6, Cortisol, and Depressive Symptoms in Ovarian Cancer Patients
2008
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
2004 Standout
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
2016 Standout
Integrated optical coherence tomography, ultrasound and photoacoustic imaging for ovarian tissue characterization
2011
What goes up does not always come down: patterns of distress, physical and psychosocial morbidity in people with cancer over a one year period
2011
Drug Resistance in Cancer: An Overview
2014 Standout
Effects of Psycho-Oncologic Interventions on Emotional Distress and Quality of Life in Adult Patients With Cancer: Systematic Review and Meta-Analysis
2013
Works of Mitchell I. Edelson being referenced
Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas
1997
Prophylactic and Risk-Reducing Bilateral Salpingo-oophorectomy
2010
Long-Term Trajectories of Psychological Adaptation Among Women Diagnosed With Gynecological Cancers
2008
Disparities Among Cervical Cancer Patients Receiving Brachytherapy
2019
Coping and communication-enhancing intervention versus supportive counseling for women diagnosed with gynecological cancers.
2007
Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations
2006
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
2016
Four-year evaluation of a psychiatric clerkship: 1982-1986
1988
Utility of Ultrasound and MRI in Prenatal Diagnosis of Placenta Accreta: A Pilot Study
2011
The biology of ovarian cancer.
1998
American College of Surgeons Clinical Congress 2014
2015
Tumor Cell-Specific BRCA1 and RASSF1A Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients
2004
Prevalence and Predictors of Psychological Distress Among Women With Ovarian Cancer
2004